Supernus Pharmaceuticals (SUPN) Inventory Average (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Inventory Average of $85.5 million for Q2 2026, up 82.98% year-over-year from $46.7 million in Q2 2025, and up 0.91% on a QoQ basis from $84.7 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Inventory Average (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Inventory Average for 15 years, with the latest figure at $85.5 million in Q2 2026.
- Inventory Average for Q2 2026 came in at $85.5 million, up 82.98% year-over-year; the trailing twelve-month figure through Jun 2026 was $85.5 million (up 82.98% YoY), and the FY2025 annual result was $68.3 million, up 3.78% from the prior year.
- Inventory Average grew to $85.5 million in Q2 2026, from $84.7 million in the prior quarter.
- Over five years, Inventory Average peaked at $91.3 million in Q1 2023 and troughed at $46.7 million in Q2 2025.
- A 5-year average of $76.6 million and a median of $82.5 million in 2022 frame the typical range for Inventory Average.
- The widest annual swing landed in 2025, when Inventory Average tumbled 34.76%; it then surged 82.98% in 2026.
- A 5-year view of Inventory Average shows it stood at $87.4 million in 2022, then declined by 7.91% to $80.4 million in 2023, then declined by 26.49% to $59.1 million in 2024, then surged by 36.79% to $80.9 million in 2025, then increased by 5.69% to $85.5 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $85.5 million in Q2 2026, $84.7 million in Q1 2026, and $80.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 85.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.49 Mn |
| Mar 31, 2026 | 84.72 Mn |
| Dec 31, 2025 | 80.89 Mn |
| Sep 30, 2025 | 61.71 Mn |
| Jun 30, 2025 | 46.72 Mn |
| Mar 31, 2025 | 51.86 Mn |
| Dec 31, 2024 | 59.14 Mn |
| Sep 30, 2024 | 66.07 Mn |
| Jun 30, 2024 | 71.62 Mn |
| Mar 31, 2024 | 76.24 Mn |
| Dec 31, 2023 | 80.44 Mn |
| Sep 30, 2023 | 87.02 Mn |
| Jun 30, 2023 | 90.85 Mn |
| Mar 31, 2023 | 91.34 Mn |
| Dec 31, 2022 | 87.35 Mn |
| Sep 30, 2022 | 84.01 Mn |
| Jun 30, 2022 | 86.83 Mn |
| Mar 31, 2022 | 87.38 Mn |
| Dec 31, 2021 | 73.06 Mn |
| Sep 30, 2021 | 59.27 Mn |